Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The nervous system's potential role in multiple sclerosis associated bone loss.
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor beta.
Internet-based social networking and its role in the evolution of chronic cerebrospinal venous insufficiency.
Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis.
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.
Simvastatin regulates oligodendroglial process dynamics and survival.
Cervical Disk Pathology in Patients With Multiple Sclerosis: Two Case Reports.
Journal Club: Intrathecal effects of daclizumab treatment of multiple sclerosis.
Animal models of multiple sclerosis: the good, the bad and the bottom line.
Targeting human oligodendrocyte progenitors for myelin repair.
Pathophysiology of the brain extracellular matrix: a new target for remyelination.
[The role of chronic venous insufficiency in the pathogenesis of brain diseases].
Minocin
Sex effects on inflammatory and neurodegenerative processes in multiple sclerosis.
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial.
Personality traits of patients with multiple sclerosis and their relationship with clinical characteristics.
Glutamate inhibition in MS: the neuroprotective properties of riluzole.
Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
The gut microbiome in multiple sclerosis.
Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases.
Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations.
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Pages
« first
‹ previous
…
222
223
224
225
226
227
228
229
230
…
next ›
last »